Navigation Links
BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
Date:9/11/2007

aureus colonization prior to surgery. For patients positive for Staphylococcus sp., decolonization with the antibiotic ointment mupirocin is recommended as a routine measure. In addition, a patient's colonization status is an important indicator in determining the appropriate prophylactic antibiotic to administer one hour prior to surgery.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 27,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com.

This press release contains certain forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future products or other events or developments that BD expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; difficulties inherent in product development and delays in product introductions; changes in reg
'/>"/>

SOURCE BD Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... France , Dec. 19, 2014  Eli Lilly ... (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide ... as BioChaperone Lispro, for treatment in people with type ... Adocia,s proprietary BioChaperone® technology and is currently in Phase ... BioChaperone Lispro with the goal of optimizing glucose levels ...
(Date:12/17/2014)... DIEGO , Dec. 17, 2014 Royal ... Volcano Corporation (NASDAQ: VOLC ), a global leader ... announced that they have entered into a definitive merger agreement. ... to acquire all of the issued and outstanding shares of ... purchase price of USD 1 billion (approx. EUR 800 million), ...
(Date:12/17/2014)... 2014 Revenue and earnings above the ... and development In the past 2013/14 fiscal year ... percent to EUR 4.287 billion (last year: EUR 4.190 billion) ... to EUR 360 million. "Overall, 2013/14 was a successful fiscal ... , President and CEO of Carl Zeiss AG. "Thanks to ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8ZEISS Asserts its Position in Difficult Environment 2
... Cellular Dynamics International (CDI) ... Endothelial Cells for use in vascular-targeted drug discovery, ... Endothelial cells make up the lining of blood ... research across a multitude of disease states.  Endothelial dysfunction ...
... Eli Lilly and Company (NYSE: LLY ... of FORTEO® (teriparatide [rDNA origin] injection) and zoledronic acid ... remodeling in transiliac crest bone biopsies from postmenopausal women ... presentation at the 2011 Annual Meeting of the American ...
Cached Medicine Technology:Cellular Dynamics Announces Commercial Launch of iCell® Endothelial Cells for Vascular-Targeted Drug Discovery 2Cellular Dynamics Announces Commercial Launch of iCell® Endothelial Cells for Vascular-Targeted Drug Discovery 3Cellular Dynamics Announces Commercial Launch of iCell® Endothelial Cells for Vascular-Targeted Drug Discovery 4New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid 2New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid 3New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid 4New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid 5New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid 6New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid 7
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once again ... provide logistics and support for one of Dallas’ largest holiday ... history of giving back to the community in which it ... Drive were Whataburger® and 99.5 The Wolf. , There is ... gifts to children who would otherwise not receive any is ...
(Date:12/22/2014)... The NLN’s 2015 Leadership Institute ... month. Faculty have been selected through competitive application ... for administrative leadership roles within their academic institutions; ... Educators, featuring a curriculum uniquely devised for up-and-comers ... , Twenty nurse educators were chosen for the ...
(Date:12/21/2014)... 22, 2014 Weddingshe.com, an outstanding online ... has recently released its new selection of Cocktail Dresses ... made according to the newest fashion trends. ... dresses for cocktail parties . All of them are ... off. We are making every effort to offer a ...
(Date:12/21/2014)... New York (PRWEB) December 21, 2014 ... and other product liability claims involving a class ... mimetics continue to move forward in a federal ... Southern District of California, Bernstein Liebhard LLP reports. ... Court has established a data cut-off date of ...
(Date:12/21/2014)... December 21, 2014 Serious Buyer, Andrew ... 1967 Jm Morrison and the Doors International Ballroom at ... would also be the only time that Morrison's mother ... on Nov. 25, 1967. According to Hawley, “This would ... did play the Alexandria Roller Rink earlier that year ...
Breaking Medicine News(10 mins):Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4
... Prime Healthcare Services,("Prime Healthcare"), has acquired ... Center from Tenet Healthcare Corporation,("Tenet") effective June ... Encino Hospital,Medical Center. Prime Healthcare also has ... additional Tenet hospitals in California --,167-bed Garden ...
... LONDON, June 2 , - Misys Trade ... Misys plc (FTSE: MSY.L), the global application ... been awarded the double accolade of,winning two SWIFTReady ... solutions., Having been the first trade services ...
... Bunk bed-related injuries are not an issue of ... a study conducted by investigators at the Center for ... Nationwide Childrens Hospital. The study, published in the June ... who sustain bunk bed-related injuries are younger than 10 ...
... baseball-related injuries has decreased within the last 10 years, ... to a new study conducted by researchers at the ... Research Institute at Nationwide Children,s Hospital. During the two-year ... occurred with an injury rate of more than one ...
... medical center, new channel hosted exclusively by doctors, available 24/7 to listeners ... ... ... Radio, features daily shows and reports on general health and, wellness, plastic surgery, ...
... into the toxins, virulence, spread and prevention of the ... issue of the Journal of Medical Microbiology. These findings ... ammunition in the fight against a sometimes deadly pathogen. ... is most common in hospitals. It can cause a ...
Cached Medicine News:Health News:Prime Healthcare Services to Acquire Three Hospitals from Tenet Healthcare Corporation 2Health News:Misys Wins Prestigious Gold Labels From SWIFT for Entire Trade Services Solutions Portfolio 2Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3Health News:Injuries to high school baseball players becoming more serious 2Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 2Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 3Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 4Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 5Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 6Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 7Health News:SIRIUS Satellite Radio & NYU Langone Medical Center Launch 'Doctor Radio' Channel 8Health News:Advances in C. difficile research 2
The advanced optics of Frequency 55 Aspheric offer an unsurpassed level of visual quality. By focusing light to a common focal point on the back of eye, instead of a general area, the aspheric design...
The proven daily wear spherical soft contact lens....
Surevue brand contact lenses deliver exceptional overall performance in a contact lens since they're easy to use and offer great comfort....
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
Medicine Products: